Thursday, May 17, 2018 10:15 AM


By Alan Mozes

HealthDay Reporter

THURSDAY, May 17, 2018 (HealthDay News) -- Male cancer[1] patients seem to fare significantly better following immunotherapy[2] treatment than female patients, new research indicates.

"Both sex and gender can potentially affect the strength of the body's immune response," explained study author Dr. Fabio Conforti, from the European Institute of Oncology in Milan, Italy.

For example, Conforti noted that women generally show stronger immune responses than men in reaction to medical treatment. That, he said, seems to explain why infections occur less frequently -- and are often less serious -- among women than men, and why women also typically respond better to vaccines[3] than men.

"On the other hand, women account for roughly 80 percent of all patients with systemic autoimmune diseases[4] worldwide," Conforti said. "Therefore, it's possible that differences in the immune system

News source: WebMD

See also: Steven Enrich